Sign in
PMCB Stock Price, Chart, Stats & News
PharmaCyte Biotech, Inc.
Save
5.22M
Market cap
–
Current P/E
7.02x
Forward P/E
PMCB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -5.87% |
ROE | -7.69% |
D/E | – |
Interest coverage ratio | – |
PMCB valuation
P/E | – |
P/S | – |
P/B | 0.17x |
P/CF | -1.37x |
P/FCF | -1.00x |
P/OCF | -1.37x |
PEG | -0.10x |
EV multiple | -1.94x |
About
PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which utilizes cellulose to enclose live cells.
Similar securities
Based on sector and market capitalization
Report issue